Precision Business Insights has published a report on the global cancer tumor profiling market, estimating its value at USD 12,806.1 Million in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 10.2% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.
View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/cancer-tumour-profiling-market
The Cancer Tumor Profiling Market is a component of the healthcare business that focuses on molecular and genetic analysis of tumor samples to enable individualized cancer therapy. This market includes technology and services for identifying particular biomarkers, mutations, and genetic properties of cancer cells, allowing doctors to personalize medicines to individual patients.
Drivers:
- Increasing global cancer incidence (e.g., 19.3 million new cases in 2020) drives demand for advanced diagnostics.
- Rapid progress in NGS, proteomics, and AI integration enables faster, more accurate profiling at lower costs.
The global cancer tumor profiling market segmentation:
1) By Cancer Type: Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Melanoma Cancer, Other Cancer
2) By technique: Genomics, Proteomics, Metabolomics, Epigenetics
3) By Application: Research, Biomarker Discovery, Personalized Medicine, Clinical Application, Diagnostics, Prognostics, Screening, Others
Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=126008
Regional Overview:
The report also examines the current concerns and their Future Effects on the cancer tumor profiling market by the region. The report covers all regions and countries, North America was the largest and Asia was the fastest-growing region in the cancer tumor profiling market. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.
- North America (U.S., Canada)
- Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
- Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
- Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)
The competitive landscape is dominated by major players like Illumina, Inc., Thermo Fisher Scientific, Inc., NanoString Technologies, Inc., QIAGEN N.V., Agilent Technologies, Inc., Genomic Health, Inc., Adaptive Biotechnologies Corporation, Caris Life Sciences, Myriad Genetics, Inc., Guardant Health, Inc., F. Hoffmann-La Roche AG, Becton, Dickinson and Company, Natera, Inc.
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
